应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06821 凯莱英
未开盘 07-29 16:08:09
43.900
-0.350
-0.79%
最高
44.700
最低
43.650
成交量
9.97万
今开
44.250
昨收
44.250
日振幅
2.37%
总市值
162.20亿
流通市值
12.10亿
总股本
3.69亿
成交额
437.15万
换手率
0.36%
流通股本
2,755万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
摩根大通减持凯莱英(06821)约17.61万股 每股作价约44.75港元
智通财经网 · 07-29 17:58
摩根大通减持凯莱英(06821)约17.61万股 每股作价约44.75港元
凯莱英(002821)7月26日主力资金净卖出202.82万元
证券之星 · 07-29 09:50
凯莱英(002821)7月26日主力资金净卖出202.82万元
北向资金7月25日净买入凯莱英13.99万股 连续3日增持
自选股智能写手 · 07-26
北向资金7月25日净买入凯莱英13.99万股 连续3日增持
凯莱英07月24日获主力加仓98万元 环比增加366.67%
自选股智能写手 · 07-24
凯莱英07月24日获主力加仓98万元 环比增加366.67%
医疗服务行业盘中跳水,凯莱英跌0.88%
自选股智能写手 · 07-24
医疗服务行业盘中跳水,凯莱英跌0.88%
北向资金7月22日净卖出凯莱英22.99万股 连续3日减持
自选股智能写手 · 07-23
北向资金7月22日净卖出凯莱英22.99万股 连续3日减持
凯莱英07月22日遭主力抛售166万元 环比增加137.14%
自选股智能写手 · 07-22
凯莱英07月22日遭主力抛售166万元 环比增加137.14%
龙头业绩预喜!CRO概念股集体狂飙,机构:全面看多下半年医药行情
格隆汇 · 07-22
龙头业绩预喜!CRO概念股集体狂飙,机构:全面看多下半年医药行情
港股概念追踪 |新签订单金额均实现两位数增长 CXO要回暖(附概念股)
智通财经 · 07-22
港股概念追踪 |新签订单金额均实现两位数增长 CXO要回暖(附概念股)
凯莱英(06821)参与投资基金完成私募投资基金备案
智通财经网 · 07-19
凯莱英(06821)参与投资基金完成私募投资基金备案
摩根大通减持凯莱英(06821)28.04万股 每股作价约45.57港元
智通财经网 · 07-19
摩根大通减持凯莱英(06821)28.04万股 每股作价约45.57港元
凯莱英(06821)上涨5.19%,报47.6元/股
金融界 · 07-17
凯莱英(06821)上涨5.19%,报47.6元/股
凯莱英(06821)股价上升5.193%,现价港币$47.6
阿斯达克财经 · 07-17
凯莱英(06821)股价上升5.193%,现价港币$47.6
港股异动 | CRO概念股集体上涨 美联储降息将近叠加利好政策频出 板块有望迎边际改善
智通财经 · 07-17
港股异动 | CRO概念股集体上涨 美联储降息将近叠加利好政策频出 板块有望迎边际改善
北向资金7月16日净买入凯莱英10.81万股 连续5日增持
自选股智能写手 · 07-17
北向资金7月16日净买入凯莱英10.81万股 连续5日增持
摩根大通减持凯莱英(06821)8.01万股 每股作价约44.71港元
智通财经 · 07-16
摩根大通减持凯莱英(06821)8.01万股 每股作价约44.71港元
北向资金7月12日净买入凯莱英12.84万股 连续3日增持
自选股智能写手 · 07-15
北向资金7月12日净买入凯莱英12.84万股 连续3日增持
凯莱英7月11日获北向资金加仓47.63万股
自选股智能写手 · 07-12
凯莱英7月11日获北向资金加仓47.63万股
凯莱英(002821)7月11日主力资金净买入1197.16万元
证券之星 · 07-12
凯莱英(002821)7月11日主力资金净买入1197.16万元
凯莱英:2024上半年营收26.60-27.40亿元,净利润4.80-5.50亿元
和讯网 · 07-11
凯莱英:2024上半年营收26.60-27.40亿元,净利润4.80-5.50亿元
加载更多
公司概况
公司名称:
凯莱英
所属市场:
SEHK
上市日期:
--
主营业务:
凯莱英医药集团(天津)股份有限公司是一家主要从事药物定制研发生产(CDMO)的中国公司。该公司的主营业务是化学药物的工艺开发、放大和商业化,产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司还从事药物制剂解决方案、生物合成解决方案和临床解决方案的提供。
发行价格:
--
{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":43.9,"timestamp":1722240489019,"preClose":44.25,"halted":0,"volume":99700,"delay":0,"floatShares":27553260,"shares":369471533,"eps":6.725592,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.35,"latestTime":"07-29 16:08:09","open":44.25,"high":44.7,"low":43.65,"amount":4371540,"amplitude":0.023729,"askPrice":43.9,"askSize":200,"bidPrice":43.75,"bidSize":600,"shortable":3,"etf":0,"ttmEps":5.675131112848429,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722303000000},"adr":0,"listingDate":1639065600000,"adjPreClose":44.25,"dividendRate":0.044075,"openAndCloseTimeList":[[1722216600000,1722225600000],[1722229200000,1722240000000]],"volumeRatio":0.310927,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":67.3,"timestamp":1722236637000,"preClose":67.61,"halted":0,"volume":2226072,"delay":0,"premium":"-39.29"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2455658925","title":"摩根大通减持凯莱英(06821)约17.61万股 每股作价约44.75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455658925","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2455658925?lang=zh_cn&edition=full","pubTime":"2024-07-29 17:58","pubTimestamp":1722247080,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,7月24日,摩根大通减持凯莱英(06821)17.6128万股,每股作价44.7471港元,总金额约为788.12万港元。减持后最新持股数目为314.3144万股,最新持股比例为11.40%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-29/doc-incfuzva5729617.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-29/doc-incfuzva5729617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0417517546.SGD","IE00BKVL7J92.USD","BK1191","LU0238689110.USD","BK4585","LU0310799852.SGD","LU1267930490.SGD","LU0070302665.USD","LU0170899867.USD","IE00BJTD4V19.USD","LU1496350171.SGD","LU0320765489.SGD","LU0882574139.USD","BK4516","BK4504","LU","LU1244550577.SGD","IE00BZ1G4Q59.USD","LU1363072403.SGD","LU1670627923.USD","BK0132","LU0976567544.SGD","LU1244550494.USD","LU1119994496.HKD","LU0496365809.HKD","IE0034235188.USD","LU0208291251.USD","LU1162221912.USD","LU0211328371.USD","LU1032466523.USD","IE00B775SV38.USD","LU1668664300.SGD","LU1496350502.SGD","BK4550","BK4566","IE00BLSP4452.SGD","BK4207","LU1244550221.USD","BK4581","IE00BFXG1179.USD","LU1084165304.USD","LU0971096721.USD","LU1670628061.USD","002821","06821","IE00BWXC8680.SGD","LU0149725797.USD","BK4588","LU0234572021.USD","LU1328615791.USD"],"gpt_icon":0},{"id":"2455508176","title":"凯莱英(002821)7月26日主力资金净卖出202.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455508176","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2455508176?lang=zh_cn&edition=full","pubTime":"2024-07-29 09:50","pubTimestamp":1722217852,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月26日收盘,凯莱英报收于67.61元,下跌0.35%,换手率0.77%,成交量2.53万手,成交额1.72亿元。近5日资金流向一览见下表:凯莱英融资融券信息显示,融资方面,当日融资买入1105.02万元,融资偿还1182.1万元,融资净偿还77.08万元。凯莱英主营业务:是一家全球领先、技术驱动型的医药外包服务一站式综合服务商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072900004036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK0239","BK1191","LU1328615791.USD","BK0132","002821"],"gpt_icon":0},{"id":"2454635676","title":"北向资金7月25日净买入凯莱英13.99万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2454635676","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454635676?lang=zh_cn&edition=full","pubTime":"2024-07-26 09:31","pubTimestamp":1721957471,"startTime":"0","endTime":"0","summary":"7月25日, 北向资金增持凯莱英13.99万股,连续3日增持。截止当日收盘,深股通共持有凯莱英1060.85万股,占流通股3.10%。凯莱英近5个交易日下跌0.37%,深股通累计增持38.96万股;近20个交易日上涨0.52%,深股通累计增持46.44万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726093812955bbcb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726093812955bbcb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2453020398","title":"凯莱英07月24日获主力加仓98万元 环比增加366.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453020398","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453020398?lang=zh_cn&edition=full","pubTime":"2024-07-24 16:15","pubTimestamp":1721808913,"startTime":"0","endTime":"0","summary":"07月24日, 凯莱英股价跌2.79%,报收43.55元,成交金额1167万元,换手率0.95%,振幅5.80%,量比0.66。凯莱英今日主力资金净流入98万元,上一交易日主力净流入21万元,今日环比增加366.67%。该股近5个交易日下跌7.45%,主力资金累计净流出82万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出483万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407241615299555dfa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407241615299555dfa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2453122960","title":"医疗服务行业盘中跳水,凯莱英跌0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453122960","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453122960?lang=zh_cn&edition=full","pubTime":"2024-07-24 10:01","pubTimestamp":1721786491,"startTime":"0","endTime":"0","summary":"07月24日,医疗服务行业盘中跳水,截至10点01分,医疗服务行业整体指数下跌1.01%,报4001.790点。从个股上来看,该行业的成分股中,凯莱英跌0.88%,华大基因、诺思格、诺泰生物跌幅居前。从资金上来看,截止发稿,医疗服务行业主力净流入为-1.00亿,其中药明康德受到资金热捧,主力净流入737.96万;拉长时间线来看,该板块近20日主力资金净流入-28.08亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724100131af93c69b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724100131af93c69b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2453721154","title":"北向资金7月22日净卖出凯莱英22.99万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2453721154","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453721154?lang=zh_cn&edition=full","pubTime":"2024-07-23 09:31","pubTimestamp":1721698269,"startTime":"0","endTime":"0","summary":"7月22日,北向资金减持凯莱英22.99万股连续3日减持。截止当日收盘,深股通共持有凯莱英989.26万股,占流通股2.89%。凯莱英近5个交易日上涨7.49%,深股通累计减持6.46万股;近20个交易日下跌1.67%,深股通累计减持103.24万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723094007955151eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723094007955151eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2453753737","title":"凯莱英07月22日遭主力抛售166万元 环比增加137.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453753737","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453753737?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:15","pubTimestamp":1721636154,"startTime":"0","endTime":"0","summary":"07月22日, 凯莱英股价涨1.98%,报收46.30元,成交金额3211万元,换手率2.50%,振幅5.18%,量比2.29。凯莱英今日主力资金净流出166万元,上一交易日主力净流出70万元,今日环比增加137.14%。该股近5个交易日上涨1.54%,主力资金累计净流出106万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流出552万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072216161095e79ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072216161095e79ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2453731253","title":"龙头业绩预喜!CRO概念股集体狂飙,机构:全面看多下半年医药行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2453731253","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453731253?lang=zh_cn&edition=full","pubTime":"2024-07-22 14:44","pubTimestamp":1721630654,"startTime":"0","endTime":"0","summary":"有望迎来边际改善","market":"hk","thumbnail":"https://img3.gelonghui.com/ace7d-6b3066d4-036c-4224-b3e3-aa509104a112.jpg?guru_height=812&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/ace7d-6b3066d4-036c-4224-b3e3-aa509104a112.jpg?guru_height=812&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/870710","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU1720050803.USD","LU0823426308.USD","LU2045819591.USD","603127","02359","LU0181495838.USD","LU1242518857.USD","BK1589","LU0326950275.SGD","09939","LU2125910500.SGD","LU0588546209.SGD","SG9999002463.SGD","LU0359201612.USD","BK0216","LU0348825331.USD","LU0979878070.USD","03759","LU0043850808.USD","BK1610","02269","LU1794554557.SGD","LU0052750758.USD","LU1880383366.USD","BK1521","BK1583","LU0572944931.SGD","BK1141","03347","LU0823426480.USD","BK1515","LU0051755006.USD","LU0456827905.SGD","LU0819121731.USD","SG9999002562.SGD","301333","LU0039217434.USD","LU0348735423.USD","06821","LU1046422090.SGD","LU0516422952.EUR","LU0516423174.USD","LU0307460666.USD","BK1574","LU0516423091.SGD","LU0708995583.HKD","LU2242644610.SGD","BK1191","01873","BK1576"],"gpt_icon":0},{"id":"2453207480","title":"港股概念追踪 |新签订单金额均实现两位数增长 CXO要回暖(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2453207480","media":"智通财经","labels":["Business Data"],"top":-1,"share":"https://www.laohu8.com/m/news/2453207480?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:05","pubTimestamp":1721610356,"startTime":"0","endTime":"0","summary":"康龙化成表示,在2024年第二季度,伴随着全球生物医药行业投融资的初步复苏,预计公司营业收入较2024年第一季度环比提高,较2023年第二季度同比实现小幅增长。康龙化成还透露,公司全球客户询单和访问较2023年同期有所回暖,新签订单金额同比增长超过15%。凯莱英:加快海外布局以及多肽产能建设,新签订单同比增长超过 20%,且二季度较一季度环比有较大幅度增长,其中来自于欧美市场客户订单增速超过公司整体订单增速水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSCEI","YANG","CXO","BK1191","HSTECH","06821"],"gpt_icon":1},{"id":"2452740004","title":"凯莱英(06821)参与投资基金完成私募投资基金备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2452740004","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452740004?lang=zh_cn&edition=full","pubTime":"2024-07-19 22:23","pubTimestamp":1721399012,"startTime":"0","endTime":"0","summary":"凯莱英(06821)公布,公司于2024年4月29 \n日召开第四届董事会第五十次会...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_20.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_20.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002821","06821","BK0132","BK0239","LU1328615791.USD","BK1191"],"gpt_icon":0},{"id":"2452426179","title":"摩根大通减持凯莱英(06821)28.04万股 每股作价约45.57港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452426179","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452426179?lang=zh_cn&edition=full","pubTime":"2024-07-19 18:10","pubTimestamp":1721383800,"startTime":"0","endTime":"0","summary":"香港联交所数据显示,7月15日,摩根大通减持凯莱英(06821)28.04万股,每股作价45.5702港元,总金额约1277.79万港元。减持后最新持股数目约为407.05万股,持股比例为14.77%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-19/doc-incesnuw5332007.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-19/doc-incesnuw5332007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1084165304.USD","LU0976567544.SGD","LU0882574139.USD","LU0211326755.USD","IE00BLSP4239.USD","BK0239","BK4534","BK4588","LU1244550494.USD","LU0238689110.USD","LU1668664300.SGD","BK4550","LU0211326839.USD","LU0496365809.HKD","BK4516","LU0417517546.SGD","IE00B1BXHZ80.USD","LU0971096721.USD","LU1162221912.USD","BK4585","LU1363072403.SGD","LU1261432733.SGD","BK4533","LU1328615791.USD","LU1496350171.SGD","IE00BZ1G4Q59.USD","LU0149725797.USD","IE00BWXC8680.SGD","LU1244550577.SGD","BK0132","IE00BFXG1179.USD","LU0170899867.USD","002821","IE00BKVL7J92.USD","IE00BLSP4452.SGD","LU0320765489.SGD","LU1267930490.SGD","LU1670627923.USD","LU0208291251.USD","LU","LU1032466523.USD","LU1670628061.USD","BK4207","LU0234572021.USD","BK4566","LU0070302665.USD","BK1191","06821","LU1496350502.SGD","LU1119994496.HKD"],"gpt_icon":0},{"id":"2452904606","title":"凯莱英(06821)上涨5.19%,报47.6元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452904606","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452904606?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:04","pubTimestamp":1721192647,"startTime":"0","endTime":"0","summary":"7月17日,凯莱英(06821)盘中上涨5.19%,截至13:04,报47.6元/股,成交1387.54万元。凯莱英医药集团是一家全球领先的CDMO公司,主要为全球新药提供从临床早期到商业化阶段的一站式研发、生产服务,包括高级中间体、原料药、制剂的研发和cGMP生产,以及临床研究服务。公司通过持续技术创新和战略合作,为国内外制药公司、生物技术公司提供药品全生命周期一站式CMC服务,加快新药开发及应用,逐步构建起创新药一体化服务生态圈。截至2024年一季报,凯莱英营业总收入13.64亿元、净利润2.82亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/17130441615421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK1191","BK0132","002821","06821","LU1328615791.USD"],"gpt_icon":0},{"id":"2452904521","title":"凯莱英(06821)股价上升5.193%,现价港币$47.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2452904521","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452904521?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:04","pubTimestamp":1721192640,"startTime":"0","endTime":"0","summary":"[上升股]凯莱英(06821) 股价在下午01:04比前收市价上升5.193%,现股价为港币$47.6。至目前为止,今日最高价为$47.6,而最低价为$45.65。总成交量为29.66万股,总成交金额为港币$1.387千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240717959/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["002821","BK0132","06821","BK0239","LU1328615791.USD","BK1191"],"gpt_icon":0},{"id":"2452908632","title":"港股异动 | CRO概念股集体上涨 美联储降息将近叠加利好政策频出 板块有望迎边际改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2452908632","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452908632?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:56","pubTimestamp":1721185003,"startTime":"0","endTime":"0","summary":"消息面上,美国6月通胀超预期回落叠加鲍威尔频频“放鸽”,当前市场预测美联储九月降息概率升至100%。开源证券此前指出,随着美联储将进入降息周期,流动性改善有助于优化投融资环境并提高新药研发景气度,有望给估值仍处于底部的创新药标的带来更大的估值修复空间。另外,利好政策频出支持创新药产业发展。该行认为,CXO板块在经历业绩、估值双杀之后,有望迎来边际改善。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IVV","07226",".SPX","SSO","BK1191","BK1141","BK1576","BK4559","YANG","BK4534","BK4550","BK4581","HSCEI","OEX","SH","SDS","OEF","01548","BK4504","03347","SPY","BK4585","BK1583","HK0000306701.USD","UPRO","HK0000306685.HKD","03759","SPXU","HSTECH","BK4588","HK0000320223.HKD","06821","HK0000320264.USD","ESmain"],"gpt_icon":0},{"id":"2452971219","title":"北向资金7月16日净买入凯莱英10.81万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452971219","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452971219?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:31","pubTimestamp":1721179863,"startTime":"0","endTime":"0","summary":"7月16日, 北向资金增持凯莱英10.81万股,连续5日增持。截止当日收盘,深股通共持有凯莱英1006.54万股,占流通股2.94%。深股通增持金额前五个股分别为京东方A、紫光股份、北方华创、许继电气、天山铝业。凯莱英近5个交易日上涨7.14%,深股通累计增持108.42万股;近20个交易日下跌9.32%,深股通累计减持155.92万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071709415095cb86ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071709415095cb86ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2451299943","title":"摩根大通减持凯莱英(06821)8.01万股 每股作价约44.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451299943","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451299943?lang=zh_cn&edition=full","pubTime":"2024-07-16 20:03","pubTimestamp":1721131424,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所数据显示,7月9日,摩根大通减持凯莱英(06821)8.01万股,每股作价44.7068港元,总金额约358.10万港元。减持后最新持股数目约491.02万股,持股比例17.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071620320195c7835a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071620320195c7835a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2451668374","title":"北向资金7月12日净买入凯莱英12.84万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2451668374","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451668374?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:31","pubTimestamp":1721007068,"startTime":"0","endTime":"0","summary":"7月12日, 北向资金增持凯莱英12.84万股,连续3日增持。截止当日收盘,深股通共持有凯莱英993.04万股,占流通股2.90%。深股通增持金额前五个股分别为比亚迪、北方华创、宁德时代、平安银行、歌尔股份。凯莱英近5个交易日上涨4.41%,深股通累计减持15.85万股;近20个交易日下跌11.05%,深股通累计减持131.02万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071509392795bd3c38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071509392795bd3c38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2450344224","title":"凯莱英7月11日获北向资金加仓47.63万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450344224","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450344224?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:31","pubTimestamp":1720747868,"startTime":"0","endTime":"0","summary":"7月11日, 北向资金增持凯莱英47.63万股。截止当日收盘,深股通共持有凯莱英980.20万股,占流通股2.86%。深股通增持金额前五个股分别为长安汽车、京东方A、宁德时代、东方雨虹、华测检测。凯莱英近5个交易日上涨8.32%,深股通累计减持7.77万股;近20个交易日下跌13.06%,深股通累计减持189.83万股。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120941089f385e0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120941089f385e0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2450497573","title":"凯莱英(002821)7月11日主力资金净买入1197.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450497573","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450497573?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:12","pubTimestamp":1720746740,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月11日收盘,凯莱英报收于66.52元,上涨7.97%,换手率2.24%,成交量7.35万手,成交额4.81亿元。近5日资金流向一览见下表:凯莱英融资融券信息显示,融资方面,当日融资买入3201.32万元,融资偿还3518.68万元,融资净偿还317.36万元。凯莱英主营业务:是一家全球领先、技术驱动型的医药外包服务一站式综合服务商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200013635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","BK0132","002821","BK0239","BK1191","06821"],"gpt_icon":0},{"id":"2450694350","title":"凯莱英:2024上半年营收26.60-27.40亿元,净利润4.80-5.50亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450694350","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450694350?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:06","pubTimestamp":1720703205,"startTime":"0","endTime":"0","summary":"快讯正文7月10日晚,凯莱英披露2024年上半年业绩预告,显示公司营收与净利润均出现显著下降。具体来看,上半年营收介于26.60亿元至27.40亿元之间,同比下降40.72%至42.45%;净利润则在4.80亿元至5.50亿元区间,同比下降67.39%至71.54%。凯莱英的主营业务分为小分子CDMO业务和非小分子CDMO业务,即新兴业务。随着GLP-1药物的火爆,凯莱英加快了海外布局和多肽产能建设,新签订单同比增长超20%,尤其是欧美市场订单增速显著。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071121164395a668be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071121164395a668be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":-0.1255},{"period":"3month","weight":-0.2755},{"period":"6month","weight":-0.3041},{"period":"1year","weight":-0.5269},{"period":"ytd","weight":-0.4957}],"compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0591},{"period":"3month","weight":-0.0357},{"period":"6month","weight":0.067},{"period":"1year","weight":-0.1333},{"period":"ytd","weight":-0.0015}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团(天津)股份有限公司是一家主要从事药物定制研发生产(CDMO)的中国公司。该公司的主营业务是化学药物的工艺开发、放大和商业化,产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司还从事药物制剂解决方案、生物合成解决方案和临床解决方案的提供。","exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}